Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

19.15USD
9:00pm BST
Change (% chg)

$0.05 (+0.26%)
Prev Close
$19.10
Open
$19.05
Day's High
$19.45
Day's Low
$18.90
Volume
74,265
Avg. Vol
152,974
52-wk High
$19.60
52-wk Low
$8.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.682
Mar '18 0.00 -0.737
FY 2017 Dec '17 0.00 -0.840
Sep '17 0.00 -1.091
Jun '17 1.39 -1.079
Mar '17 0.16 -1.535
FY 2016 Dec '16 0.84 -1.712
Sep '16 162.84 1.627
Jun '16 14.07 -1.719
Mar '16 12.36 -1.673
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.75 3.00 0.00 37.78
Year Ending Dec-19 5 85.06 127.31 40.00 197.33
Earnings (per share)
Quarter Ending Sep-18 5 -0.73 -0.61 -0.82 -0.82
Quarter Ending Dec-18 5 -0.76 -0.71 -0.84 -0.79
Year Ending Dec-18 6 -2.92 -2.76 -3.07 -2.75
Year Ending Dec-19 6 -1.30 1.49 -2.95 -0.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.72 30.39
P/E High - Last 5 Yrs. -- 271.03 47.38
P/E Low - Last 5 Yrs. -- 94.74 24.76
Beta 3.66 0.77 0.84
Price to Sales (TTM) -- 126.38 5.97
Price to Book (MRQ) 20.51 12.33 3.68
Price to Tangible Book (MRQ) 21.62 18.28 5.55
Price to Cash Flow (TTM) -- 59.02 20.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.46 -6.01
Payout Ratio(TTM) -- 6.12 46.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 160.40 7.40
Sales (TTM) vs TTM 1 Yr. Ago -100.00 92.02 6.42
Sales - 5 Yr. Growth Rate -3.91 24.32 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.76 75.74 23.76
EPS (TTM) vs TTM 1 Yr. Ago -24.16 -- --
EPS - 5 Yr. Growth Rate -- 23.18 7.50
Capital Spending - 5 Yr. Growth Rate 20.73 36.89 8.03

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.66 2.50
Current Ratio (MRQ) 7.78 5.35 3.53
LT Debt to Equity (MRQ) 161.99 17.95 11.23
Total Debt to Equity (MRQ) 161.99 20.97 14.17
Interest Coverage (TTM) -12.30 -189.65 31.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.07 55.31
Gross Margin - 5 Yr. Avg. -- 52.57 53.32
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -257.41 -189.87 15.82
Operating Margin (TTM) -- -674.65 3.86
Operating Margin - 5 Yr. Avg. -261.31 -203.27 10.94
Pre-Tax Margin (TTM) -- -666.53 4.16
Pre-Tax Margin - 5 Yr. Avg. -285.97 -204.44 11.11
Net Profit Margin (TTM) -- -656.77 0.97
Net Profit Margin - 5 Yr. Avg. -285.97 -202.01 7.46
Effective Tax Rate (TTM) -- 11.17 20.37
Effective Tax Rate - 5 Yr. Avg. -- 18.61 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,094,116 721,828,383
Net Income/Employee (TTM) -1,606,959 -6,334,673 84,004,691
Receivable Turnover (TTM) -- 5.49 5.38
Inventory Turnover (TTM) -- 2.11 3.51
Asset Turnover (TTM) 0.00 0.38 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -108.75 0.13 10.03
Return on Assets - 5 Yr. Avg. -101.49 2.30 10.96
Return on Investment (TTM) -128.54 0.92 12.61
Return on Investment - 5 Yr. Avg. -168.01 1.68 14.17
Return on Equity (TTM) -411.26 -0.89 14.80
Return on Equity - 5 Yr. Avg. -- -7.01 15.53
  1 Year 3 Year 5 Year
Sales % -99.18 -63.15 -3.91
EPS (TTM) % -47.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Coherus BioSciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.76%
# of Holders: 186
Total Shares Held: 63,589,636
3 Mo. Net Change: 6,496,889
# New Positions: 32
# Closed Positions: 19
# Increased Positions: 105
# Reduced Positions: 48
# Net Buyers: 57
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.